UNSPSC 51373424: Chlorpheniramine/codeine/phenylephrine/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373424 Chlorpheniramine/codeine/phenylephrine/phenylpropanolamine is a Commodity code under which state and local governments procure pharmaceutical products, specifically multi-source generic medications and over-the-counter drugs distributed through authorized wholesale channels to public health facilities, community health departments, and emergency response programs. The solicitations show purchasing bodies acquiring both branded pharmaceutical formulations and generic equivalents for emergency medical use and community health initiatives, with vendors supplying products through established wholesale distribution networks that serve multiple state and local end-users simultaneously. Issuing bodies include county health departments and state-administered cooperative purchasing alliances that aggregate demand across multiple jurisdictions; Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the active buyer types, with MMCAP pulling demand from participating state agencies, local governments, and facilities across multiple states including Oregon.

Recent activity concentrates in Florida and Minnesota, with MMCAP's multi-state cooperative vehicle expanding reach across participating jurisdictions beyond those two anchors. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract includes a two-year initial term with optional one-year renewal and is potentially FEMA-funded. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 on January 20, 2026, with a March 26, 2026 response deadline, to establish multi-award contracts for generic pharmaceuticals and OTC products supplied through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, with contract effectiveness July 1, 2026 for a two-year term and optional extensions. Vendors in both solicitations must maintain comprehensive insurance, comply with FDA and cGMP requirements, and certify E-Verify and drug-free workplace compliance where applicable.